Blog
RSS FeedPosted by Michael Wonder on 08 Sep 2021
Congress is ready to dig into drug prices
7 September 2021 - After months of drama and procedural votes, Congress is about to dive into the legislative process on ...
Posted by Michael Wonder on 07 Sep 2021
To lower drug costs, define ‘cost’ to mean net cost after rebates
7 September 2021 - In what could be a turning point in the prescription drug debate, President Biden has made ...
Posted by Michael Wonder on 06 Sep 2021
Democrats’ plans to introduce prescription drug pricing reform face formidable obstacles
6 September 2021 - For years, reducing prescription drug prices has been a policy goal of (mostly Democratic) legislators at the ...
Posted by Michael Wonder on 06 Sep 2021
Congress “concerned by apparent anomalies” around FDA’s approval of Aduhelm
6 September 2021 - Congress demands more information from the FDA on its controversial approval of Biogen’s Alzheimer’s drug and its ...
Posted by Michael Wonder on 05 Sep 2021
America desperately needs a much better FDA
2 September 2021 - In the early 1960s, an unflappable FDA scientist named Frances Kelsey spared the nation from the horrors ...
Posted by Michael Wonder on 04 Sep 2021
Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
3 September 2021 - As Democrats design a way to use the government’s leverage to lower drug prices for seniors, ...
Posted by Michael Wonder on 02 Sep 2021
House Committees demand FDA records on Alzheimer’s drug approval
2 September 2021 - The agency approved Biogen’s Aduhelm “despite concerns raised by experts,” committee leaders said in a letter. ...
Posted by Michael Wonder on 02 Sep 2021
FDA reaches milestone in competitive generic therapy drug approvals
2 September 2021 - This week, the FDA reached the milestone of approving more than 100 generic drug applications with a ...
Posted by Michael Wonder on 02 Sep 2021
Political preoccupation with prescription drug costs may distract from larger problem of hospital costs
2 September 2021 - It’s no secret that per capita health care costs are very high in the U.S. This wouldn’t ...
Posted by Michael Wonder on 02 Sep 2021
FDA to hold Advisory Committee meeting to discuss Pfizer-BioNTech’s application for COVID-19 booster
2 September 2021 - Today, the U.S. FDA announced a virtual meeting of its Vaccines and Related Biological Products Advisory ...
Posted by Michael Wonder on 01 Sep 2021
FDA requires warnings about increased risk of serious heart related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions
1 September 2021 - Based on a completed U.S. FDA review of a large randomised safety clinical trial, we have concluded ...
Posted by Michael Wonder on 28 Aug 2021
PhRMA's Steve Ubl: CBO report makes clear "patients face future with less hope under Congress' drug pricing plan"
27 August 2021 - Pharmaceutical Research and Manufacturers of America president and CEO Stephen J. Ubl made the following statement after ...
Posted by Michael Wonder on 26 Aug 2021
Biden Administration likely to approve COVID-19 boosters at six months
26 August 2021 - Pfizer, BioNTech have requested clearance for COVID-19 vaccine boosters that an official said could be administered six ...
Posted by Michael Wonder on 25 Aug 2021
Don’t meddle with Medicare to save a budget
25 August 2021 - House Democrats this week approved a $3.5 trillion budget framework that has already passed the Senate. ...
Posted by Michael Wonder on 24 Aug 2021
FDA, drug makers propose new pilots aimed at speeding rare disease drugs, as part of user fee update
23 August 2021 - The FDA and the drug industry have jointly agreed to create several new pilot programs aimed ...